We shown that CYR61 and TAZ are up-regulated in BE index biopsies (negative for dysplasia) from patients that progress to cancer (P-BE), years before the development of EA as compared to index biopsies from BE patients that did not progress (non P-BE). This evidence concerns the gene CCN1 and dysplasia.